Zobrazeno 1 - 10
of 39
pro vyhledávání: '"PIEPER, MP"'
Autor:
PROFITA, M, BONANNO, A, SIENA, L, BRUNO, A, FERRARO, M, MONTALBANO, AM, RICCOBONO, L, CASAROSA, P, PIEPER, MP, GJOMARKAJ, M., ALBANO, Giusy Daniela
Acetylcholine (ACh), synthesized by choline acetyltransferase (ChAT), and muscarinic M1, M2, and M3 receptors (MRs) are involved in fibroblast proliferation. We evaluated ChAT, MRs, and extracellular signal-regulated kinase (ERK) 1/2 and nuclear fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::862723b07e5e56293af503b56b06fa93
http://hdl.handle.net/10447/58337
http://hdl.handle.net/10447/58337
Autor:
Ander Vergara, Conxita Jacobs-Cacha, Carmen Llorens-Cebria, Alberto Ortiz, Irene Martinez-Diaz, Nerea Martos, Pamela Dominguez-Báez, Mireia Molina Van den Bosch, Sheila Bermejo, Michael Paul Pieper, Begoña Benito, Maria Jose Soler
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 12823
Scientia
Scientia
Chronic kidney disease; Diabetic nephropathy; Endothelin receptor antagonists Enfermedad renal crónica; Nefropatía diabética; Antagonistas de los receptores de endotelina Malaltia renal crònica; Nefropatia diabètica; Antagonistes dels receptors
Autor:
Angela Marina Montalbano, Maria Ferraro, Mirella Profita, Stefania Gerbino, Giusy Daniela Albano, Loredana Riccobono, Mark Gjomarkaj, Anna Bonanno, Paola Casarosa, Michael P. Pieper
Publikováno v:
Immunobiology. 217:345-353
Novel pharmacological strategies are aimed at the resolution of systemic inflammation in COPD potentiating peripheral blood T-cell (PBT-cell) apoptosis. Although muscarinic acetylcholine receptors (mAChRs) M(3) and choline-acetyltransferase (ChAT) pa
Autor:
Mark Gjomarkaj, Angela Marina Montalbano, Maria Ferraro, Andreina Bruno, Liboria Siena, Michael P. Pieper, Paola Casarosa, Giusy Daniela Albano, Stefania Girbino, Anna Bonanno, Mirella Profita
Aims Acetylcholine (ACh) is synthesized by Choline Acetyl-Transferase (ChAT) that exerts its physiological effects in airway epithelial cells via muscarinic receptor (MR) activation. We evaluate the effect of ACh stimulation on human bronchial epithe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b77eae87375649ead1832997b80952f7
http://hdl.handle.net/10447/58334
http://hdl.handle.net/10447/58334
Autor:
Chen S; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Department of Anesthesiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Wang Q; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Department of Anesthesiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Bakker D; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Department of Anesthesiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Hu X; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Department of Anesthesiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Zhang L; Dalton Cardiovascular Research Center, University of Missouri, Columbia, USA., van der Made I; Department of Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Tebbens AM; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Department of Anesthesiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Kovácsházi C; HUN-REN-SU System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089, Budapest, Hungary., Giricz Z; HUN-REN-SU System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089, Budapest, Hungary.; Pharmahungary Group, 6722, Szeged, Hungary., Brenner GB; HUN-REN-SU System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089, Budapest, Hungary., Ferdinandy P; HUN-REN-SU System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089, Budapest, Hungary.; Pharmahungary Group, 6722, Szeged, Hungary., Schaart G; Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands., Gemmink A; Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands., Hesselink MKC; Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands., Rivaud MR; Department of Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Pieper MP; CardioMetabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany., Hollmann MW; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Department of Anesthesiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Weber NC; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Department of Anesthesiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Balligand JL; Pole of Pharmacology and Therapeutics, Institut de Recherche Experimentale et Clinique (IREC) and Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium., Creemers EE; Department of Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Coronel R; Department of Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Zuurbier CJ; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Department of Anesthesiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. c.j.zuurbier@amsterdamumc.nl.
Publikováno v:
Basic research in cardiology [Basic Res Cardiol] 2024 Oct; Vol. 119 (5), pp. 751-772. Date of Electronic Publication: 2024 Jul 24.
Autor:
Fakih W; University of Strasbourg, UR 3074, Translational Cardiovascular Medicine, Biomedicine Research Center of Strasbourg, 1 Rue Eugène Boeckel, 67000 Strasbourg, France., Mroueh A; University of Strasbourg, UR 3074, Translational Cardiovascular Medicine, Biomedicine Research Center of Strasbourg, 1 Rue Eugène Boeckel, 67000 Strasbourg, France., Gong DS; University of Strasbourg, UR 3074, Translational Cardiovascular Medicine, Biomedicine Research Center of Strasbourg, 1 Rue Eugène Boeckel, 67000 Strasbourg, France., Kikuchi S; University of Strasbourg, UR 3074, Translational Cardiovascular Medicine, Biomedicine Research Center of Strasbourg, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.; Cardiology Department, Strasbourg University Hospital, 1 place de l'Hôpital, 67000 Strasbourg, France., Pieper MP; Boehringer Ingelheim Pharma GmbH & Co. KG, Global Cardio-Metabolic Diseases, Birkendorfer Strasse 65, 88397 Biberach, Germany., Kindo M; Cardiology Department, Strasbourg University Hospital, 1 place de l'Hôpital, 67000 Strasbourg, France., Mazzucottelli JP; Cardiology Department, Strasbourg University Hospital, 1 place de l'Hôpital, 67000 Strasbourg, France., Mommerot A; Cardiology Department, Strasbourg University Hospital, 1 place de l'Hôpital, 67000 Strasbourg, France., Kanso M; Cardiology Department, Strasbourg University Hospital, 1 place de l'Hôpital, 67000 Strasbourg, France., Ohlmann P; Cardiology Department, Strasbourg University Hospital, 1 place de l'Hôpital, 67000 Strasbourg, France., Morel O; University of Strasbourg, UR 3074, Translational Cardiovascular Medicine, Biomedicine Research Center of Strasbourg, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.; Cardiology Department, Strasbourg University Hospital, 1 place de l'Hôpital, 67000 Strasbourg, France., Schini-Kerth V; University of Strasbourg, UR 3074, Translational Cardiovascular Medicine, Biomedicine Research Center of Strasbourg, 1 Rue Eugène Boeckel, 67000 Strasbourg, France., Jesel L; University of Strasbourg, UR 3074, Translational Cardiovascular Medicine, Biomedicine Research Center of Strasbourg, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.; Cardiology Department, Strasbourg University Hospital, 1 place de l'Hôpital, 67000 Strasbourg, France.
Publikováno v:
Cardiovascular research [Cardiovasc Res] 2024 Sep 02; Vol. 120 (10), pp. 1138-1154.
Autor:
Profita M; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy. Electronic address: profita@ibim.cnr.it., Albano GD; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy; Dipartimento Biomedico di Medicina, Interna e Specialistica (Di.Bi.M.I.S.), Sezione di Pneumologia, University of Palermo, Palermo, Italy., Riccobono L; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Di Sano C; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Montalbano AM; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Gagliardo R; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Anzalone G; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Bonanno A; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Pieper MP; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Gjomarkaj M; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy.
Publikováno v:
Immunobiology [Immunobiology] 2024 Sep; Vol. 229 (5), pp. 152806. Date of Electronic Publication: 2024 Jun 29.
Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome.
Autor:
Ge M; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida., Molina J; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida., Tamayo I; Center for Precision Medicine, School of Medicine, University of Texas Health San Antonio, San Antonio, Texas., Zhang G; Center for Precision Medicine, School of Medicine, University of Texas Health San Antonio, San Antonio, Texas., Kim JJ; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida., Njeim R; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida., Fontanesi F; Department of Biochemistry and Molecular Biology, University of Miami, Miami, Florida., Pieper MP; Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Merscher S; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida., Sharma K; Center for Precision Medicine, School of Medicine, University of Texas Health San Antonio, San Antonio, Texas., Fornoni A; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida.
Publikováno v:
Kidney360 [Kidney360] 2024 Jul 01; Vol. 5 (7), pp. 1002-1011. Date of Electronic Publication: 2024 May 23.
Autor:
Profita M; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy. Electronic address: profita@ibim.cnr.it., Riccobono L; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Montalbano AM; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Bonanno A; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Ferraro M; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Albano GD; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Gerbino S; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Casarosa P; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Pieper MP; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Gjomarkaj M; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy.
Publikováno v:
Immunobiology [Immunobiology] 2024 May; Vol. 229 (3), pp. 152800. Date of Electronic Publication: 2024 Apr 18.